Clinical Trial Update: Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle [EARLY_Phase 1]

View source ↗

Summary

This early Phase 1 clinical trial is evaluating whether dexmedetomidine, as part of an ICU sleep-promotion bundle, reduces delirium days in critically ill patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium
• Sleep Disorders

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: University of Alberta | Conditions: Sleep, Delirium | EARLY_Phase 1 | Status: NOT_YET_RECRUITING